Kyle Fletcher - Jul 13, 2022 Form 4 Insider Report for Celularity Inc (CELU)

Role
General Counsel
Signature
/s/ Keary Dunn, Attorney-in-Fact
Stock symbol
CELU
Transactions as of
Jul 13, 2022
Transactions value $
$0
Form type
4
Date filed
7/15/2022, 08:30 PM
Next filing
Nov 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELU Class A Common Stock Award $0 +2.3K +6.93% $0.00 35.4K Jul 13, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELU Stock Option (Right to Buy) Award $0 +6.74K $0.00 6.74K Jul 13, 2022 Class A Common Stock 6.74K $10.16 Direct F2
transaction CELU Stock Option (Right to Buy) Award $0 +125K $0.00 125K Jul 13, 2022 Class A Common Stock 125K $4.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
F2 This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date.
F3 This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.